AIG
ADMS

American International Group’s Adamas Pharmaceuticals ADMS Stock Holding History

American International Group’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,524
Closed -$39K – 3204
2020
Q1 		$39K Sell
13,524
-781
-5% -$3.5K ﹤0.01% 2781
2019
Q4 		$54K Buy
14,305
+48
+0.3% +$230 ﹤0.01% 2862
2019
Q3 		$73K Sell
14,257
-100
-0.7% -$617 ﹤0.01% 2760
2019
Q2 		$89K Buy
14,357
+166
+1% +$955 ﹤0.01% 2747
2019
Q1 		$101K Sell
14,191
-461
-3% -$4.14K ﹤0.01% 2617
2018
Q4 		$125K Buy
14,652
+79
+0.5% +$1.03K ﹤0.01% 2477
2018
Q3 		$292K Buy
14,573
+262
+2% +$6.15K ﹤0.01% 2189
2018
Q2 		$370K Buy
14,311
+3,323
+30% +$92K ﹤0.01% 2017
2018
Q1 		$263K Buy
10,988
+932
+9% +$29.4K ﹤0.01% 2117
2017
Q4 		$341K Buy
10,056
+233
+2% +$6.51K ﹤0.01% 2006
2017
Q3 		$208K Buy
9,823
+734
+8% +$13.5K ﹤0.01% 2269
2017
Q2 		$159K Sell
9,089
-1,195
-12% -$19.8K ﹤0.01% 2422
2017
Q1 		$180K Buy
10,284
+682
+7% +$11.6K ﹤0.01% 2251
2016
Q4 		$162K Sell
9,602
-25
-0.3% -$387 ﹤0.01% 2324
2016
Q3 		$158K Buy
9,627
+14
+0.1% +$213 ﹤0.01% 2327
2016
Q2 		$146K Buy
9,613
+3,526
+58% +$58.1K ﹤0.01% 2359
2016
Q1 		$88K Hold
6,087
– – ﹤0.01% 3526
2015
Q4 		$172K Sell
6,087
-11
-0.2% -$185 ﹤0.01% 2993
2015
Q3 		$102K Buy
6,098
+7
+0.1% +$159 ﹤0.01% 3466
2015
Q2 		$160K Buy
6,091
+4,254
+232% +$82.7K ﹤0.01% 3217
2015
Q1 		$32.1K Hold
1,837
– – ﹤0.01% 4165
2014
Q4 		$31.9K Sell
1,837
-74
-4% -$1.12K ﹤0.01% 4164
2014
Q3 		$35.6K Hold
1,911
– – ﹤0.01% 4113
2014
Q2 		$34.9K Buy
+1,911
New +$34.2K ﹤0.01% 4095

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

American International Group's ADMS Position: Q2 2020 in Review

American International Group sold out of Adamas Pharmaceuticals (ADMS) in Q2 2020, closing a stake of 13,524 shares — an estimated $39K sold.

American International Group first reported a position in ADMS in Q2 2014 and held it in 24 quarters. The position peaked at $370K in Q2 2018. 61 funds tracked by Wall St. Rank hold ADMS as of Q2 2020.

  • American International Group reported no remaining Adamas Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • American International Group sold 13,524 Adamas Pharmaceuticals shares in Q2 2020, an estimated $39K.
  • American International Group first reported a position in Adamas Pharmaceuticals in Q2 2014 and held it in 24 quarters.
  • American International Group's Adamas Pharmaceuticals position peaked at $370K in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2020.

Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.